In vivo effects of topical anti-psoriatic treatments on cutaneous inflammation, epidermal proliferation and keratinisation

Current Drug Therapy

Volumn 2, Issue 1, 2007, Pages 21-26

  van de Kerkhof, Peter C M ^a   Jorn Bovenschen, H ^a   Körver, John E M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Calcipotriol; Lesional Skin; Neutrophils; T cell activation; Transit amplifying cells (TAC)

Indexed keywords

ANTIPSORIASIS AGENT; BETAMETHASONE; BETAMETHASONE DIPROPIONATE; BETAMETHASONE DIPROPIONATE PLUS CALCIPOTRIOL; BUDESONIDE; CALCIPOTRIOL; CALCITRIOL; CD161 ANTIGEN; CD2 ANTIGEN; CD4 ANTIGEN; CD45RA ANTIGEN; CD45RO ANTIGEN; CD8 ANTIGEN; CD94 ANTIGEN; CLOBETASOL; CLOBETASOL PROPIONATE; CLOBETASONE; COLECALCIFEROL DERIVATIVE; CORTICOSTEROID; DITHRANOL; FILAGGRIN; INTERLEUKIN 2 RECEPTOR ALPHA; INVOLUCRIN; KI 67 ANTIGEN; TACALCITOL;

CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL DENSITY; CELL GROWTH; CELL PROLIFERATION; COMBINATION CHEMOTHERAPY; DRUG EFFECT; DRUG RESPONSE; EPIDERMIS CELL; HUMAN; IN VIVO STUDY; KERATINIZATION; LANGERHANS CELL; MESENCHYME CELL; MITOSIS INHIBITION; MONOCYTE; MONOTHERAPY; NATURAL KILLER T CELL; NEUTROPHIL; PATHOGENESIS; PRIORITY JOURNAL; PSORIASIS; REVIEW; SKIN INFLAMMATION; SYMPTOMATOLOGY; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

EID: 34248183693     PISSN: 15748855     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488507779422428     Document Type: Review

References (38)

1. Baker BS, Swain AD, Fry L, Valdimarsson H. Epidermal T lymphocytes and HLA-DR expression in psoriasis. Br J Dermatol 1984;110:555-564.
2. +) T cells appear early in the margin of spreading psoriatic lesions in contrast to cells expressing natural killer receptors, which appear late. Br J Dermatol 2004; 150:852-859.
3. Prinz JC. Disease mimicry - a pathogenetic concept for T cell-mediated autoimmune disorders triggered by molecular mimicry? Autoimmun Rev 2004; 3:10-5.
4. Smith CH, Barker JN. Pathogenic aspects of psoriasis: cell trafficking and role of adhesion molecules in psoriasis. In: Pathogenic Aspects of Psoriasis. PCM van de Kerkhof and JD Bos (eds), Elsevier, New York, pp. 151-160.
5. Nickoloff BJ, Bonish B, Huang BB, Porcelli SA. Characterization of T cell line bearing natural killer receptors and capable of creating psoriasis in ASCID mouse model. J Dermatol Sci 2000; 24: 212-225.
6. Sugiyama H, Gyulai R, Toichi E, et al. Dysfunctional blood and target issue CD4+ CD25 high regulatory T cells in psoriasis: mechanisms underlying unrestrained pathogenic effector T cell proliferation. J Immunol 2005; 174: 164-73.
7. MacKie EJ, Halfter W, Liverani D. Induction of tenascin in healing wounds. J Cell Biol 1988; 107:2757-2767.
8. Watt FM. The stem cell compartment in human interfollicular epidermis. J Dermatol Sci 2002; 28:173-180.
9. Jones PH. Epithelial stem cells. Bio essay 1997;119:638-690.
10. Körver JEM, Duijnhoven MWFM van, Pasch MC, Erp PEJ van, Kerkhof PCM van de. Assessment of epidermal subpopulations and proliferation in healthy skin symptomless and lesional skin of spreading psoriasis. Br J Dermatol, (in press).
11. Wasseem A, Dogan B, Tidman N, et al. Keratin 15 expression in stratified epithelia: downregulation in activated keratinocytes. J Invest Dermatol 1999;112:362-9.
12. Kerkhof PCM van de, Erp van. Pathogenesis. In textbook of psoriasis 2ed. Ed Kerkhof PCM van de. Blackwell Publishing 2003, London, pp. 83-109.
13. Jong EMGJ de, Schalkwijk J, Kerkhof PCM van de. Epidermal proliferation and differentiation composition of the inflammatory infiltrate and the extra cellular matrix in the margin of the spreading psoriatic lesion. Eur J Dermatol 1991;1:221-227.
14. Gerritsen MJP, Elbers ME, Jong EMGJ de, Kerkhof PCM van de. Recruitment of cycling epidermal cells and expression of filaggrin, involucrin and tenascin in the margin of the active psoriatic plaque, in the uninvolved skin of psoriatic patients and in the normal healthy skin. J Dermatol Sci 1997;14(3):179-88.
15. 3 analogue MC 903. Br J Dermatol 1990;123:291-6.
16. 3 analogue MC 903: modulations and interrelations. Br J Dermatol 1991;124;221-9.
17. Jong EMGJ de, Kerkhof PCM van de. Short contact dithranol treatment of psoriasis, using a novel emulsifying ointment (Hermal AWR) changes in clinical scores and in parameters for inflammation, proliferation and keratinization. European Journal of Dermatology 1992;2:552-8.
18. Jong EMGJ de, Ferrier CM, Zwart A de, Wouben-Perros PJ, Korstanje C, Kerkhof PCM van de. Effects of topical treatment with budesonide on parameters for epidermal proliferation, kerathinization and inflammation. J Dermatol Sci 1995; 9: 185-94.
19. 3: a cell biological study. Br J Dermatol 1993; 128:666-673.
20. 3) on cutaneous inflammation, epidermal proliferation and keratinization in psoriasis, a placebo-controlled, double-blind study. Br J Dermatol 1994; 131:57-63.
21. Gerritsen MJP, Vlijmen-Willems IMJJ van, Chang A, Kerkhof PCM van de. The effect of a hydrocolloid occlusive dressing (DuoDERM E) on keratinization in psoriasis vulgaris. Accepted Acta Dermato Vernereol (Stockholm). 1994;74:483-84.
22. Castelijns FACM, Gerritsen MJP, Erp PEJ van, Kerkhof PCM van de. Efficacy of Calcipotriol ointment under hydrocolloid occlusion in psoriasis. Dermatology 2000; 200:25-30.
23. Vleuten CJM van der, Jong EMGJ de, Kerkhof PCM van de. Epidermal differentiation characteristics of the psoriatic plaque during treatment with Calcipotriol. Arch Dermatol Res 1996; 288:366-72.
24. Castelijn FACM, Gerritsen MJP, Vlijmen IMJJ van, Erp PEJ van, Kerkhof PCM van de. Proliferation is the main target in the treatment of psoriatic plaques with once daily an application of Tacalcitol ointment. Acta Derm Venereol 1998;78:111-4.
25. Mommers RJM, Castelijns FACM, Seegers BAMPA, Rossum MM van, Hooydonk CAEM van, Erp PEJ van, Kerkhof PCM van de. The effect of long-term treatment with Tacalcitol on the psoriatic epidermis, a flow cytometric analysis. Br J Dermatol 1998; 139: 468-71.
26. Vleuten CJM van der, Jong EMGJ de, Kerkhof PCM van de. Epidermal differentiation characteristics of the psoriatic plaque during short contact treatment with dithranol cream. Clin Exp Dermatol 1996; 21:409-14.
27. Vleuten CJM, Vlijmen-Willem IMJJ van, Jong EMGJ de, Kerkhof PCM van de. Clobetasol 17 propionate lotion under hydrocolloid dressing (Duoderm ET) once weekly versus unoccluded clobetasol-17-propionate ointment twice daily in psoriasis: an immunohistochemical study remission and relapse. Arch Derm Res 1999; 291: 390-5.
28. Swinkels, OQJ, Prins M, Gerritsen MJP, Vlijmen-Willems IMJJ' van, Valk PGM van der, Kerkhof PCM van de. An immunohistochemical assessment of the response of the psoriatic lesion to single and repeated application of high dose dithranol cream. Skin Pharmacol Appl Skin Physiol 2002;15: 393-400.
29. 3: a multi parameter flow cytometrical analysis of epidermal growth, differentiation and inflammation. Acta Derm Venereol 1995; 75:385-5.
30. Glade CP, Erp PEJ van, Kerkhof PCM van de. Epidermal cell DNA content and intermediate filaments keratin 10 and vimentin after treatment of psoriasis with Calcipotriol cream once daily, twice daily and in combination with clobetasone 17- leukyrate cream or betamethasone 17 vale rate cream: a comparative flow cytometric study. Br J Dermatol 1996; 135:379-81.
31. Glade CP, Vleuten CJM van der, Erp PEJ van. Flow cytometric assessment of clearance and relapse characteristics in psoriasis vulgaris after treatment with weekly clobetasol lotion under occlusion versus twice daily clobetasol ointment. Skin Pharmacol Appl Physiol 2002; 15: 92-99.
32. Mommers JM, Erp PEJ van, Kerkhof PCM van de. Clobetasol under hydrocolloid occlusion in psoriasis results in a complete black of proliferation and in a rebound of lesions following discontinuation. Dermatology 1999;159:323-7.
33. Franssen MEJ, Jongh GJ de, Erp PEJ van, Kerkhof PCM van de. A left/ right comparison of twice daily calcipotriol ointment and calcitriol ointment in patients with psoriasis: the effect on keratinocyte subpopulations. Acta Derm Venereol 2004; 84:195-200.
34. Rossum MM van, Erp PEJ van, Kerkhof PCM van de. Treatment of psoriasis with a new combination of calcipotriol and betamethasone dipropionate: a flow cytometric study. Dermatology 2001; 203: 148-52.
35. Vleuten CJM van der, Gerritsen MJP, Jong EMGJ de, Elber M, Jongh GJ de, Kerkhof PCM van de. A novel dithranol formulation (Micanol): The effects of monotherapy and UVB combination therapy on epidermal differentiation proliferation and cutaneous inflammation in psoriasis vulgaris. Acta Derm Venereol 1996; 76: 387-91.
36. Vissers WHPM, Berends M, Muys L, Erp PEJ van, Jong EMGJ de, Kerkhof PCM van de. The effect of the combination of calcipotriol and betamethasone dipropionate versus both monotherapies on epidermal proliferation, keratinization and T-cell subsets in chronic plaque psoriasis. Exp Dermatol 2004; 13:106-12.
37. Vissers WHPM, Hoogen GAL van de, Kerkhof PCM van de. Dithranol cream has no effect on lesional T-cell subsets during a 6 week treatment course for plaque psoriasis, Manuscript in preparation.
38. Bovenschen HJ, Vissers WHPM, Seyger MMB, Kerkhof PCM van de. Selective persistence of dermal CD8+ T cells in lesional plaque psoriasis after clobetasol-17 propionate treatment. Acta Derm Verenerol 2005;85:113-7.